April 15, 2016
Specialized research and development (R&D) labs including contract organizations (CROs, CMOs etc.) in all sectors are under extreme pressure to develop new formulations quickly (as fast as possible) and effectively (as close to specification as possible).
December 16, 2014
Drug development in the UK took center stage recently, as life sciences minister George Freeman set out his initiatives to make Britain “the best place in the world to get quicker access for patients to innovative medicines”. The Government also announced the Innovative Medicines and Medical Technology review for 2015, which will seek to integrate the NHS more closely with pharma and life sciences research organizations. But was the focus right?
May 7, 2014
The recent news that Boris Johnson has launched MedCity is a welcome investment in the life sciences arena. It is encouraging to see the well-known research hubs of the UK, namely Oxford and Cambridge, are included in the ‘Golden triangle’ with London. The question to pose is whether the investment of £4 million is great enough? And it is essential to understand what MedCity will actually deliver.
April 9, 2014
Relentless business pressures are forcing some interesting changes to the way research and development (R&D) focused organizations are working and the informatics they use. Mobile technologies rank top of the list with the promise of on-the-go data and applications. Getting companies working more with mobile solutions is the next step in moving the paperless laboratory to the mobile-augmented laboratory.
August 19, 2013
The first ever comprehensive guide to experimental methodology for LC-MC bioanalysis (BA) is due to be published shortly. Edited by experts from Novartis Institutes for Biomedical Research, the Handbook of LC-MS Bioanalysis* is the result of an impressive collaboration from across a wide spectrum of the BA community spanning global pharma, regulators including the FDA and technology vendors. The Handbook looks likely to become the authoritative source on scientific, regulatory, quality and technology levers within the BA space.